
    
      A prospective, single arm, open label, multi-center, trial to evaluate the safety and
      effectiveness of the Interscope EndoRotorÂ® Resection System in subjects requiring direct
      endoscopic necrosectomy with walled off pancreatic necrosis (WOPN). Total enrollment 30
      subjects with at least 15 enrolled in the US.

      Subjects will be debrided with the EndoRotor either at the time of stent placement or post
      placement at Investigator's discretion with a maximum of 4 EndoRotor procedures. A minimum of
      2 days is required between each EndoRotor procedure and all procedures need to be completed
      within a 14 (+7/-0) day period. Follow up is completed 21 (+/- 7) days after last EndoRotor
      debridement procedure.
    
  